• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Med (Lausanne) . Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospectiv

tetano

Editor, Senior Moderator
Front Med (Lausanne)


. 2022 Dec 6;9:1067082.
doi: 10.3389/fmed.2022.1067082. eCollection 2022.
Clinical and biochemical characteristics of people experiencing post-coronavirus disease 2019-related symptoms: A prospective follow-up investigation


Assim A Alfadda[SUP] 1 2 3 [/SUP], Mohamed Rafiullah[SUP] 1 [/SUP], Mohammad Alkhowaiter[SUP] 3 [/SUP], Naif Alotaibi[SUP] 4 [/SUP], Musa Alzahrani[SUP] 3 5 [/SUP], Khalifa Binkhamis[SUP] 6 [/SUP], Khalid Siddiqui[SUP] 1 [/SUP], Amira Youssef[SUP] 1 [/SUP], Haifa Altalhi[SUP] 7 [/SUP], Ibrahim Almaghlouth[SUP] 8 [/SUP], Mohammed Alarifi[SUP] 9 [/SUP], Saleh Albanyan[SUP] 3 [/SUP], Mohammed F Alosaimi[SUP] 10 [/SUP], Arthur Isnani[SUP] 2 [/SUP], Shaik Sarfaraz Nawaz[SUP] 1 [/SUP], Khalid Alayed[SUP] 3 5 [/SUP]



Affiliations

Abstract

Background: Post-acute coronavirus disease 2019 (COVID-19) syndrome, also known as long COVID, is a prolonged illness after the acute phase of COVID-19. Hospitalized patients were known to have persisting symptoms of fatigue, headache, dyspnea, and anosmia. There is a need to describe the characteristics of individuals with post-COVID-19 symptoms in comparison to the baseline characteristics.
Purpose: To investigate the clinical and biochemical characteristics of people who recovered from COVID-19 after 6 months of discharge from the hospital.
Methods: This was a prospective follow-up investigation of hospitalized and discharged COVID-19 patients. Adult patients admitted to King Saud University Medical City, Riyadh, Saudi Arabia, with laboratory-confirmed COVID-19 and discharged were recruited. The baseline demographic information, comorbidities, vital signs and symptoms, laboratory parameters, COVID-19 therapy, and outcomes were collected from the medical records. Blood samples were collected for cytokines estimation. A detailed interview about signs and symptoms was undertaken during the follow-up.
Results: Half of the followed-up people reported experiencing at least one of the COVID-19-related symptoms. The mean blood pressure was found higher in follow-up. People with the symptoms were characterized by low lymphocyte count, lower serum calcium levels, and hyperglycemia compared to people without any post-COVID-19 symptoms. Cytokines IL-8, VEGF, and MCP-1 were higher in people with the most frequent symptoms.
Conclusion: People with post-COVID-19 symptoms were characterized by lower lymphocyte count, lower serum calcium levels, and hyperglycemia compared to people without symptoms. Individuals with the most frequent post-COVID-19 symptoms had higher baseline pro-inflammatory, chemotactic, and angiogenic cytokines.

Keywords: COVID-19; PASC; SARS-CoV-2; long COVID; post-COVID-19.
 
Back
Top Bottom